Iron and neurodegeneration: From cellular homeostasis to disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Batista Nascimento, Liliana ^a   Pimentel, Catarina ^a   Andrade Menezes, Regina ^a   Rodrigues Pousada, Claudina ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S; CELLULAR HOMEOSTASIS; EUKARYOTIC ORGANISMS; FRIEDREICH'S ATAXIAS; GENETIC FACTORS; HUNTINGTON'S DISEASE; NEURODEGENERATION; NEURODEGENERATIVE DISORDERS; NEUROLOGICAL DISORDERS; NEURONAL DYSFUNCTION; THERAPEUTIC STRATEGY;

YEAST;

NEURODEGENERATIVE DISEASES;

AMYLOID PRECURSOR PROTEIN; CERULOPLASMIN; CLIOQUINOL; DEFEROXAMINE; FERRITIN; FRATAXIN; IRON; NEUROMELANIN; PANTOTHENATE KINASE 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CATALYSIS; CELL DEATH; CEREBELLUM; CHELATION; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FRIEDREICH ATAXIA; GASTROINTESTINAL TRACT; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; LIPID PEROXIDATION; MICROGLIA; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; REVIEW; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; STRIATE CORTEX; SUBSTANTIA NIGRA; BIOLOGICAL MODEL; BRAIN; DEGENERATIVE DISEASE; HOMEOSTASIS; METABOLISM; PATHOLOGY;

BRAIN; HOMEOSTASIS; HUMANS; IRON; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SACCHAROMYCES CEREVISIAE;

EID: 84862293528     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/128647     Document Type: Review

References (88)

1. Beard J. L., Wiesinger J. A., Connor J. R., Pre- and postweaning iron deficiency alters myelination in sprague-dawley rats Developmental Neuroscience 2003 25 5 308 315 (Pubitemid 37465056)
2. Dexter D. T., Sian J., Jenner P., Marsden C. D., Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia Advances in Neurology 1993 60 273 281
3. Jomova K., Valko M., Advances in metal-induced oxidative stress and human disease Toxicology 2011 283 2-3 65 87
4. Nez M. T., Urrutia P., Mena N., Aguirre P., Tapia V., Salazar J., Iron toxicity in neurodegeneration. Biometals. In press
5. Hentze M. W., Muckenthaler M. U., Andrews N. C., Balancing acts: molecular control of mammalian iron metabolism Cell 2004 117 3 285 297 (Pubitemid 38534536)
6. Rouault T. A., The role of iron regulatory proteins in mammalian iron homeostasis and disease Nature Chemical Biology 2006 2 8 406 414 (Pubitemid 44114917)
7. Ponka P., Beaumont C., Richardson D. R., Function and regulation of transferrin and ferritin Seminars in Hematology 1998 35 1 35 54 (Pubitemid 28047041)
8. Koorts A. M., Viljoen M., Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion Archives of Physiology and Biochemistry 2007 113 1 30 54 (Pubitemid 46825687)
9. Wilczynska A., Aigueperse C., Kress M., Dautry F., Weil D., The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules Journal of Cell Science 2005 118 5 981 992 (Pubitemid 40484888)
10. Galy B., Ferring D., Benesova M., Benes V., Hentze M. W., Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo RNA 2004 10 7 1019 1025 (Pubitemid 38822138)
11. Theil E. C., Eisenstein R. S., Combinatorial mRNA regulation: iron regulatory proteins and iso-iron-responsive elements (Iso-IREs) Journal of Biological Chemistry 2000 275 52 40659 40662 (Pubitemid 32054880)
12. Romney S. J., Thacker C., Leibold E. A., An Iron Enhancer Element in the FTN-1 gene directs iron-dependent expression in Caenorhabditis elegans intestine Journal of Biological Chemistry 2008 283 2 716 725
13. Li L., Bagley D., Ward D. M., Kaplan J., Yap5 is an iron-responsive transcriptional activator that regulates vacuolar iron storage in yeast Molecular and Cellular Biology 2008 28 4 1326 1337 (Pubitemid 351214134)
14. Abboud S., Haile D. J., A novel mammalian iron-regulated protein involved in intracellular iron metabolism Journal of Biological Chemistry 2000 275 26 19906 19912 (Pubitemid 30441595)
15. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S. J., Moynihan J., Paw B. H., Drejer A., Barut B., Zapata A., Law T. C., Brugnara C., Lux S. E., Pinkus G. S., Pinkus J. L., Kingsley P. D., Palls J., Fleming M. D., Andrews N. C., Leonard Z., Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter Nature 2000 403 6771 776 781 (Pubitemid 30111839)
16. McKie A. T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T. J., Farzaneh F., Hediger M. A., Hentze M. W., Simpson R. J., A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation Molecular Cell 2000 5 2 299 309 (Pubitemid 30628088)
17. Harris Z. L., Durley A. P., Man T. K., Gitlin J. D., Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux Proceedings of the National Academy of Sciences of the United States of America 1999 96 19 10812 10817 (Pubitemid 29442226)
18. Anderson G. J., Wang F., Essential but toxic: controlling the flux of iron in the body. Clinical and Experimental Pharmacology and Physiology. In press
19. Kell D. B., Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases BMC Medical Genomics 2009 2, article 2
20. Pardridge W. M., Eisenberg J., Jing Yang, Human blood-brain barrier transferrin receptor Metabolism 1987 36 9 892 895 (Pubitemid 17135085)
21. Burdo J. R., Connor J. R., Brain iron uptake and homeostatic mechanisms: an overview BioMetals 2003 16 1 63 75 (Pubitemid 36140216)
22. Faucheux B. A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A., Leveugle B., Kubis N., Hauw J. J., Agid Y., Hirsch E. C., Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease Proceedings of the National Academy of Sciences of the United States of America 1995 92 21 9603 9607
23. Salvador G. A., Iron in neuronal function and dysfunction BioFactors 2010 36 2 103 110
24. Bartzokis G., Sultzer D., Mintz J., Holt L. E., Marx P., Phelan C. K., Marder S. R., In vivo evaluation of brain iron in alzheimer's disease and normal subjects using MRI Biological Psychiatry 1994 35 7 480 487 (Pubitemid 24122331)
25. Bartzokis G., Cummings J. L., Markham C. H., Marmarelis P. Z., Treciokas L. J., Tishler T. A., Marder S. R., Mintz J., MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects Magnetic Resonance Imaging 1999 17 2 213 222 (Pubitemid 29053180)
26. Jurgens C. K., Jasinschi R., Ekin A., MRI T2 hypointensities in basal ganglia of premanifest Huntington's disease PLoS Currents 2010 2
27. Duyn J. H., High-field MRI of brain iron Methods in Molecular Biology 2011 711 239 249
28. Zecca L., Zucca F. A., Costi P., Tampellini D., Gatti A., Gerlach M., Riederer P., Fariello R. G., Ito S., Gallorini M., Sulzer D., The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour Journal of Neural Transmission, Supplement 2003 65 145 155 (Pubitemid 38339952)
29. Harrison P. M., Arosio P., The ferritins: molecular properties, iron storage function and cellular regulation Biochimica et Biophysica Acta 1996 1275 3 161 203 (Pubitemid 26248989)
30. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., Giaveri G., Arosio P., Santambrogio P., Fariello R. G., Karatekin E., Kleinman M. H., Turro N., Hornykiewicz O., Zucca F. A., The role of iron and molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging Proceedings of the National Academy of Sciences of the United States of America 2004 101 26 9843 9848 (Pubitemid 38869324)
31. Qian Z. M., Shen X., Brain iron transport and neurodegeneration Trends in Molecular Medicine 2001 7 3 103 108 (Pubitemid 32201671)
32. Halliwell B., Reactive oxygen species and the central nervous system Journal of Neurochemistry 1992 59 5 1609 1623
33. Halliwell B., Free radicals, proteins and DNA: oxidative damage versus redox regulation Biochemical Society Transactions 1996 24 4 1023 1027 (Pubitemid 26417963)
34. Lill R., Dutkiewicz R., Elssser H. P., Hausmann A., Netz D. J. A., Pierik A. J., Stehling O., Urzica E., Mhlenhoff U., Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes Biochimica et Biophysica Acta 2006 1763 7 652 667 (Pubitemid 44189544)
35. Keller J. N., Mark R. J., Bruce A. J., Blanc E., Rothstein J. D., Uchida K., Waeg G., Mattson M. P., 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes Neuroscience 1997 80 3 685 696 (Pubitemid 27334614)
36. Ross C. A., Poirier M. A., Protein aggregation and neurodegenerative disease Nature Medicine 2004 10 S10 S17
37. Smith M. A., Harris P. L. R., Sayre L. M., Perry G., Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9866 9868 (Pubitemid 27408156)
38. Fulga T. A., Elson-Schwab I., Khurana V., Steinhilb M. L., Spires T. L., Hyman B. T., Feany M. B., Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo Nature Cell Biology 2007 9 2 139 148 (Pubitemid 46420856)
39. Piero D. J., Hu J., Connor J. R., Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains Cellular and Molecular Biology 2000 46 4 761 776
40. Jomova K., Valko M., Importance of iron chelation in free radical-induced oxidative stress and human disease Current Pharmaceutical Design 2011 17 31 3460 3473
41. Takeda A., Smith M. A., Avil J., Nunomura A., Siedlak S. L., Zhu X., Perry G., Sayre L. M., In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of induced by 4-hydroxy-2-nonenal modification Journal of Neurochemistry 2000 75 3 1234 1241 (Pubitemid 30660513)
42. Shimohama S., Tanino H., Kawakami N., Okamura N., Kodama H., Yamaguchi T., Hayakawa T., Nunomura A., Chiba S., Perry G., Smith M. A., Fujimoto S., Activation of NADPH oxidase in Alzheimer's disease brains Biochemical and Biophysical Research Communications 2000 273 1 5 9 (Pubitemid 30426853)
43. Grnblatt E., Bartl J., Riederer P., The link between iron, metabolic syndrome, and Alzheimer's disease Journal of Neural Transmission 2011 118 3 371 379
44. Rogers J. T., Randall J. D., Cahill C. M., Eder P. S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S. S., Utsuki T., Greig N. H., Lahiri D. K., Tanzi R. E., Bush A. I., Giordano T., Gullans S. R., An iron-responsive element type II in the 5′ -untranslated region of the Alzheimer's amyloid precursor protein transcript Journal of Biological Chemistry 2002 277 47 45518 45528 (Pubitemid 36159162)
45. Duce J. A., Tsatsanis A., Cater M. A., James S. A., Robb E., Wikhe K., Leong S. L., Perez K., Johanssen T., Greenough M. A., Cho H. H., Galatis D., Moir R. D., Masters C. L., McLean C., Tanzi R. E., Cappai R., Barnham K. J., Ciccotosto G. D., Rogers J. T., Bush A. I., Iron-export ferroxidase activity of -amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 2010 142 6 857 867
46. Jankovic J., Parkinson's disease: clinical features and diagnosis Journal of Neurology, Neurosurgery and Psychiatry 2008 79 4 368 376 (Pubitemid 351441488)
47. Irizarry M. C., Growdon W., Gomez-Isla T., Newell K., George J. M., Clayton D. F., Hyman B. T., Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain -synuclein immunoreactivity Journal of Neuropathology and Experimental Neurology 1998 57 4 334 337 (Pubitemid 28182631)
48. Spillantini M. G., Schmidt M. L., Lee V. M. Y., Trojanowski J. Q., Jakes R., Goedert M., -synuclein in Lewy bodies Nature 1997 388 6645 839 840
49. Dexter D. T., Wells F. R., Agid F., Agid Y., Lees A. J., Jenner P., Marsden C. D., Increased nigral iron content in postmortem Parkinsonian brain The Lancet 1987 2 8569 1219 1220 (Pubitemid 17156630)
50. Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K., Youdim M. B. H., Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains Journal of Neurochemistry 1989 52 2 515 520 (Pubitemid 19037617)
51. Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F., Agid Y., Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis Journal of Neurochemistry 1991 56 2 446 451 (Pubitemid 21901982)
52. Youdim M. B. H., Ben-Shachar D., Riederer P., Iron in brain function and dysfunction with emphasis on Parkinson's disease European Neurology 1991 31 supplement 1 34 40
53. Jomova K., Vondrakova D., Lawson M., Valko M., Metals, oxidative stress and neurodegenerative disorders Molecular and Cellular Biochemistry 2010 345 1-2 91 104
54. Hashimoto M., Takeda A., Hsu L. J., Takenouchi T., Masliah E., Role of cytochrome c as a stimulator of -synuclein aggregation in Lewy body disease Journal of Biological Chemistry 1999 274 41 28849 28852
55. Li W., Jiang H., Song N., Xie J., Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells Neurotoxicity Research 2011 19 3 435 442
56. Graham R. K., Deng Y., Slow E. J., Haigh B., Bissada N., Lu G., Pearson J., Shehadeh J., Bertram L., Murphy Z., Warby S. C., Doty C. N., Roy S., Wellington C. L., Leavitt B. R., Raymond L. A., Nicholson D. W., Hayden M. R., Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin Cell 2006 125 6 1179 1191 (Pubitemid 43866195)
57. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N., Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 1997 277 5334 1990 1993 (Pubitemid 27449140)
58. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. M. K., Bird E. D., Beal M. F., Oxidative damage and metabolic dysfunction in huntington's disease: selective vulnerability of the basal ganglia Annals of Neurology 1997 41 5 646 653 (Pubitemid 27212659)
59. Bartzokis G., Cummings J., Perlman S., Hance D. B., Mintz J., Increased basal ganglia iron levels in Huntington disease Archives of Neurology 1999 56 5 569 574 (Pubitemid 29218152)
60. Bartzokis G., Tishler T. A., MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease Cellular and Molecular Biology 2000 46 4 821 833
61. Curtis A. R. J., Fey C., Morris C. M., Bindoff L. A., Ince P. G., Chinnery P. F., Coulthard A., Jackson M. J., Jackson A. P., McHale D. P., Hay D., Barker W. A., Markham A. F., Bates D., Curtis A., Burn J., Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease Nature Genetics 2001 28 4 350 354 (Pubitemid 32702424)
62. Rouault T. A., Iron on the brain Nature Genetics 2001 28 4 299 300 (Pubitemid 32702411)
63. Zhou B., Westaway S. K., Levinson B., Johnson M. A., Gitschier J., Hayflick S. J., A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome Nature Genetics 2001 28 4 345 349 (Pubitemid 32702423)
64. Hayflick S. J., Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name Current Opinion in Pediatrics 2003 15 6 572 577 (Pubitemid 37487371)
65. Rakba N., Aouad F., Henry C., Caris C., Morel I., Baret P., Pierre J. L., Brissot P., Ward R. J., Lescoat G., Crichton R. R., Iron mobilisation and cellular protection by a new synthetic chelator O- Trensox Biochemical Pharmacology 1998 55 11 1797 1806 (Pubitemid 28305262)
66. Ke Y., Qian Z. M., Iron misregulation in the brain: a primary cause of neurodegenerative disorders The Lancet Neurology 2003 2 4 246 253 (Pubitemid 37443312)
67. Hellman N. E., Gitlin J. D., Ceruloplasmin metabolism and function Annual Review of Nutrition 2002 22 439 458 (Pubitemid 35221468)
68. Perez C. A., Tong Y., Guo M., Iron chelators as potential therapeutic agents for Parkinson's disease Current Bioactive Compounds 2008 4 3 150 158
69. Wang Y., Branicky R., Stepanyan Z., Carroll M., Guimond M. P., Hihi A., Hayes S., McBride K., Hekimi S., The anti-neurodegeneration drug clioquinol inhibits the aging-associated protein CLK-1 Journal of Biological Chemistry 2009 284 1 314 323
70. Li X., Jankovic J., Le W., Iron chelation and neuroprotection in neurodegenerative diseases Journal of Neural Transmission 2011 118 3 473 477
71. Andrade R. G. Jr., Ginani J. S., Lopes G. K. B., Dutra F., Alonso A., Hermes-Lima M., Tannic acid inhibits invitro iron-dependent free radical formation Biochimie 2006 88 9 1287 1296 (Pubitemid 44419533)
72. Tenreiro S., Outeiro T. F., Simple is good: yeast models of neurodegeneration FEMS Yeast Research 2010 10 8 970 979
73. Khurana V., Lindquist S., Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? Nature Reviews Neuroscience 2010 11 6 436 449
74. Bleackley M. R., MacGillivray R. T. A., Transition metal homeostasis: from yeast to human disease BioMetals 2011 24 5 785 809
75. Dancis A., Klausner R. D., Hinnebusch A. G., Barriocanal J. G., Genetic evidence that ferric reductase is required for iron uptake in Saccharomyces cerevisiae Molecular and Cellular Biology 1990 10 5 2294 2301
76. Georgatsou E., Alexandraki D., Two distinctly regulated genes are required for ferric reduction, the first step of iron uptake in Saccharomyces cerevisiae Molecular and Cellular Biology 1994 14 5 3065 3073 (Pubitemid 24132720)
77. Felice M. R., De Domenico I., Li L., Ward D. M., Bartok B., Musci G., Kaplan J., Post-transcriptional regulation of the yeast high affinity iron transport system Journal of Biological Chemistry 2005 280 23 22181 22190 (Pubitemid 40827874)
78. Philpott C. C., Protchenko O., Response to iron deprivation in Saccharomyces cerevisiae Eukaryotic Cell 2008 7 1 20 27 (Pubitemid 351959590)
79. Nevitt T., War-Fe-Re: iron at the core of fungal virulence and host immunity BioMetals 2011 24 3 547 558
80. Harris Z. L., Davis-Kaplan S. R., Gitlin J. D., Kaplan J., A fungal multicopper oxidase restores iron homeostasis in aceruloplasminemia Blood 2004 103 12 4672 4673 (Pubitemid 38746002)
81. Puig S., Askeland E., Thiele D. J., Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation Cell 2005 120 1 99 110 (Pubitemid 40094606)
82. Puig S., Vergara S. V., Thiele D. J., Cooperation of two mRNA-binding proteins drives metabolic adaptation to iron deficiency Cell Metabolism 2008 7 6 555 564 (Pubitemid 351729206)
83. Urbanowski J. L., Piper R. C., The iron transporter Fth1p forms a complex with the Fet5 iron oxidase and resides on the vacuolar membrane Journal of Biological Chemistry 1999 274 53 38061 38070 (Pubitemid 30026876)
84. Campuzano V., Montermini L., Molt M. D., Pianese L., Cossée M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Caizares J., Koutnikova H., Bidichandani S. I., Gellera C., Brice A., Trouillas P., De Michele G., Filla A., De Frutos R., Palau F., Patel P. I., Di Donato S., Mandel J. L., Cocozza S., Koenig M., Pandolfo M., Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 1996 271 5254 1423 1427 (Pubitemid 26089479)
85. Babcock M., De Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., Pandolfo M., Kaplan J., Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin Science 1997 276 5319 1709 1712 (Pubitemid 27421980)
86. Cavadini P., Gellera C., Patel P. I., Isaya G., Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae Human Molecular Genetics 2000 9 17 2523 2530
87. Lodi R., Cooper J. M., Bradley J. L., Manners D., Styles P., Taylor D. J., Schapira A. H. V., Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia Proceedings of the National Academy of Sciences of the United States of America 1999 96 20 11492 11495 (Pubitemid 29487408)
88. Lei P., Ayton S., Finkelstein D. I., Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export Nature Medicine 2012 18 2 291 295